Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843512 · ClinicalTrials.gov registry record
Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication
A clinical trial of Weight Loss and Food Selection, sponsored by Penn State University.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT06843512: Recruiting study of Weight Loss and Food Selection, sponsored by Penn State University.
NCT06843512 is a study of Weight Loss and Food Selection that is actively recruiting participants, run by Penn State University. The registered enrollment target is 25 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06843512, a study of Weight Loss and Food Selection, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.
Conditions Studied
Interventions
- OTHER GLP-1 Medication Initiation
Study Locations (1)
Pennsylvania
- Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-07-15 |
| Est. Completion | 2026-12 |
What NCT06843512 shows while recruiting
NCT06843512 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Weight Loss appearing as the primary indexed condition, and to 1 intervention - of which GLP-1 Medication Initiation is the first listed.
NCT06843512 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06843512 about?
NCT06843512 is a clinical study titled "Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication". In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and am...
What is the current status of trial NCT06843512?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-07-15. Estimated completion is 2026-12.
What conditions does trial NCT06843512 study?
This clinical trial studies the following conditions: Weight Loss, Food Selection.
What interventions are being tested in trial NCT06843512?
The interventions under investigation include: GLP-1 Medication Initiation (OTHER).
Who is sponsoring clinical trial NCT06843512?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843512 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06843512's enrollment target sits among peer trials
25 106th of 116 higher than 10 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss
RECRUITING
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Fasted vs. Fed State Exercise
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI